4 Results

People

  1. Landau
    Landau
  2. Chung
    Chung
  3. Giralt
    Giralt
  4. Hassoun
    Hassoun
  5. Hoover
    Hoover
  6. Lahoud
    Lahoud
  7. Scordo
    Scordo
  8. Shah
    Shah
  9. Datta
    Datta
  10. Gupta
    Gupta

Groups

  1. Bone Marrow Transplant (4)
  2. Center for Hematologic Malignancies (4)
  3. Department of Medicine (4)
  4. Hematologic Malignancies, Division of (4)
  5. Survivorship Research (4)
  6. CTCR Scholars (3)
  7. Myeloma (3)
  8. Hematologic Malignancies Research (2)
  9. Sloan Kettering Institute Postdocs (2)
  10. Biostatistics Service (1)
  1. "Clinical Lymphoma, Myeloma and Leukemia"
  2. "Elizabeth Hoover"
Formats
  1. Meeting Abstract (4)
Groups
  1. Bone Marrow Transplant (4)
  2. Center for Hematologic Malignancies (4)
  3. Department of Medicine (4)
  4. Hematologic Malignancies, Division of (4)
  5. Survivorship Research (4)
  6. CTCR Scholars (3)

More Groups

People
  1. Elizabeth Hoover (4)
  2. Heather Landau (4)
  3. Oscar Lahoud (4)
  4. David Chung (3)
  5. Gunjan Shah (3)
  6. Hani Hassoun (3)

More People

Years
  1. 2023 (1)
  2. 2022 (1)
  3. 2019 (2)
Publications
  1. Clinical Lymphoma, Myeloma and Leukemia (4)
Publishers
  1. Elsevier Inc. (4)

Results (4)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Adding Plinabulin to pegfilgrastim to shorten neutropenia and improve quality of life peri-autologous hematopoietic cell transplant for multiple myeloma
    Meeting Abstract

    Shah, G.; Hanley, D.; Datta, A.; Kamrowski, A.; Chung, D.; Gupta, G.; Hassoun, H.; Hoover, E.; Hultcrantz, M.; Korde, N.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2023)

    Fulltext@MSK | Save
  • Plinabulin after autologous hematopoietic cell transplant to decrease duration of neutropenia and improve quality of life peri-transplant
    Meeting Abstract

    Shah, G.; Shulman, L.; Hanley, D.; Chung, D.; Datta, A.; Dhar, P.; Gupta, G.; Hassoun, H.; Hoover, E.; Hultcrantz, M.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2022)

    Fulltext@MSK | Save
  • A phase 1/2 study to assess safety and dose of ixazomib in combination with cyclophosphamide and dexamethasone in newly diagnosed patients with light chain (AL) amyloidosis
    Meeting Abstract

    Sanchez, L.; Landau, H.; Rosenbaum, C.; Abrahams, A.; Chin, C.; Liotta, B.; Agudo, N.; Ramnath, S.; Hoover, E.; Rahman, H.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2019)

    Fulltext@MSK | Save
  • Interleukin-6 (IL-6) blockade with siltuximab peri-autologous hematopoietic stem cell transplantation (AHCT) may reduce symptom burden by altering the cytokine milieu in older patients with multiple myeloma (MM)
    Meeting Abstract

    Shah, G.; Holder, J.; Cho, S.; Murata, K.; Devlin, S.; Hoover, E.; Chung, D.; Dahi, P.; Lahoud, O.; Scordo, M.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2019)

    Fulltext@MSK | Save